Bahar Gholipour is a freelance science journalist based in New York. She focuses on the brain, neuroscience and psychology, and is passionate about reporting on artificial intelligence, genetics and the politics of healthcare. Her writing has appeared in various print and online publications including WIRED, New York Magazine and Scientific American. Bahar has a Masters degree in neuroscience from Ecole Normale Superieure in Paris, and has done graduate-level work at Stony Brook University’s School of Journalism.
Bahar Gholipour
Contributing writer
The Transmitter
From this contributor
In memoriam: Yves Frégnac, influential and visionary French neuroscientist
Frégnac, who died on 18 October at the age of 73, built his career by meeting neuroscience’s complexity straight on.
In memoriam: Yves Frégnac, influential and visionary French neuroscientist
Mistaking a duck for a skvader: How a conceptual form of circular analysis may taint many neuroscience studies
These logical loops are harder to spot than circularity involving noise in the data, but they result from neglecting something closer to home: existing knowledge about the brain.
Mistaking a duck for a skvader: How a conceptual form of circular analysis may taint many neuroscience studies
Double immune hit challenges female mice’s resistance to autism
Female mice can withstand a maternal antibody that triggers brain abnormalities and autism-like behaviors in males. But additional immune challenges spell trouble.
Double immune hit challenges female mice’s resistance to autism
New technique records neuronal teamwork in live mice
A new imaging technique detects specific groups of firing neurons in the brains of moving mice, enabling scientists to study brain activity linked to a particular behavior.
New technique records neuronal teamwork in live mice
Leaky mitochondria may play central role in fragile X syndrome
Some traits of fragile X syndrome may be due to problems with mitochondria, the cell’s energy factories.
Leaky mitochondria may play central role in fragile X syndrome
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.